Will personalised medicine become the norm of cancer treatment? In this Science Surgery instalment, we asked experts for their thoughts on this question.
Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer.
Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments.
The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.
We're backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.
Combining MRI scans could help spot where tumours are short of oxygen, helping to personalise treatment
Advances in MRI technology could help scientists and doctors tailor cancer treatment by measuring the oxygen levels inside tumours.